Covered recipient · General Payments record
CASSANDRA CHITOPOULOS
Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease
General Payments · PY2018–2024
$1,538.37
- Reported across 55 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $204.36 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $63.97 | 3 |
| Mallinckrodt Hospital Products Inc. | $29.94 | 1 |
| Shionogi Inc | $27.69 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $24.67 | 1 |
| ViiV Healthcare Company | $23.37 | 1 |
| ABBVIE INC. | $18.53 | 1 |
| Merck Sharp & Dohme Corporation | $16.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.53 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106912898 | CMS |
| Boston Scientific Corporation | $24.67 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092422113 | CMS |
| GlaxoSmithKline, LLC. | $21.61 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116619099 | CMS |
| GlaxoSmithKline, LLC. | $27.04 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116409591 | CMS |
| GlaxoSmithKline, LLC. | $15.32 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116263164 | CMS |
| Mallinckrodt Hospital Products Inc. | $29.94 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145163366 | CMS |
| Merck Sharp & Dohme LLC | $16.19 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141655269 | CMS |
| Shionogi Inc | $27.69 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154331414 | CMS |
| ViiV Healthcare Company | $23.37 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1112733525 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.